Wiersinga WJ, Rhoades A, Cheng A, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID19): a review. JAMA 2020;324(8):782–793. DOI: 10.1001/ jama.2020.12839.
Fu B, Xu X, Wei H. Why tocilizumab could be an effective treatment for severe COVID-19? J Transl Med 2020;18(1):164. DOI: 10.1186/s12967-020-02339-3.
Tleyjeh IM, Kashour Z, Damlaj M, et al. Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clin Microbiol Infect 2021;27(2):215–227. DOI: 10.1016/j.cmi.2020.10.036.
Salvati L, Occhipinti M, Gori L, et al. Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett 2020;228:122–128. DOI: 10.1016/j.imlet.2020.10.009.
